Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Risk and Benefit Perception Scale Development, 32571 [2015-14027]
Download as PDF
<![CDATA[
32571
Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices
tool for monitoring of the P&As,
including the public input requirement.
Furthermore, it will provide an
overview of program priorities, and
permit AIDD to track accomplishments
against goals, permitting the formulation
of technical assistance and compliance
with the Developmental Disabilities
Assistance and Bill of Rights Act of
2000.
Submit written comments on the
collection of information by August 10,
2015.
ADDRESSES: Submit written comments
on the collection of information by
email to: Valerie.Bond@aoa.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Valerie Bond, Administration on
Community Living, Administration on
Intellectual and Developmental
Disabilities, Office of Program Support,
DATES:
One Massachusetts Avenue NW., Room
4302, Washington, DC 20201, 202–690–
5841.
SUPPLEMENTARY INFORMATION: In
compliance with the requirements of
section 506 (c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration on Community Living is
soliciting public comment on the
specific aspects of the information
collection described above. Copies of
the proposed collection of information
can be obtained and comments may be
forwarded by writing to: Valerie Bond,
Administration on Community Living,
Administration on Intellectual and
Developmental Disabilities, Office of
Program, One Massachusetts Avenue,
NW., Room 4302, Washington, DC
20201.
The Department specifically requests
comments on: (a) Whether the proposed
Collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden information to be
collected; and (e) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection technique
comments and or other forms of
information technology. Consideration
will be given to comments and
suggestions submitted within 60 days of
this publication.
Respondents: 57 Protection and
Advocacy Systems
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
State Developmental Disabilities Council 5-Year State Plan ..........................
57
1
44
2,508
Estimated Total Annual Burden
Hours: 2,508.
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
Dated: June 3, 2015.
Kathy Greenlee,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2015–14050 Filed 6–8–15; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0373]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Risk and Benefit Perception Scale
Development
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Risk and Benefit Perception Scale
Development’’ has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:12 Jun 08, 2015
Jkt 235001
On
November 28, 2015, the Agency
submitted a proposed collection of
information entitled ‘‘Risk and Benefit
Perception Scale Development’’ to OMB
for review and clearance under 44
U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
OMB has now approved the information
collection and has assigned OMB
control number 0910–0784. The
approval expires on May 31, 2018. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
Dated: June 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–14027 Filed 6–8–15; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0672]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Prominent and Conspicuous Mark of
Manufacturers on Single-Use Devices
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled,
‘‘Prominent and Conspicuous Mark of
Manufacturers on Single-Use Devices’’
has been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On April
23, 2015, the Agency submitted a
proposed collection of information
entitled, ‘‘Prominent and Conspicuous
Mark of Manufacturers on Single-Use
Devices’’ to OMB for review and
clearance under 44 U.S.C. 3507. An
SUMMARY:
E:\FR\FM\09JNN1.SGM
09JNN1
]]>Agencies
[Federal Register Volume 80, Number 110 (Tuesday, June 9, 2015)]
[Notices]
[Page 32571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14027]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0373]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Risk and Benefit Perception Scale
Development
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Risk and Benefit Perception Scale
Development'' has been approved by the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On November 28, 2015, the Agency submitted a
proposed collection of information entitled ``Risk and Benefit
Perception Scale Development'' to OMB for review and clearance under 44
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0784.
The approval expires on May 31, 2018. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.reginfo.gov/public/do/PRAMain.
Dated: June 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-14027 Filed 6-8-15; 8:45 am]
BILLING CODE 4164-01-P
